SC379069 · Active · incorporated 16 years, 5 months ago · Kilmacolm
Medtech AI Diagnostics Drug Discovery Healthcare Series B+
Develops AI-driven precision cancer diagnostics, including tests for predicting patient toxicity to chemotherapy.
Oxford Cancer Biomarkers Limited is a private limited company registered at Companies House under number SC379069, incorporated on 24 May 2010, with a registered office in Kilmacolm. Its current status on the register is active. Its filed nature of business is other human health activities (SIC 86900). Sonde has indexed 135 filings for this company, including 7 funding rounds. Its most recent round closed in June 2024, raising £131k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 7 | Jun 2024 | £131k | £469.24 |
| Round 6 | Apr 2023 | £719k | £949.37 |
| Round 5 | Jul 2019 | £801k | £1,415.93 |
| Round 4 | Jan 2019 | £2.2m | £1,415.70 |
| Round 3 | May 2017 | £3.1m | £1,250.10 |
| Round 2 | Jan 2016 | £900k | £181.00 |
Showing the 6 most recent of 7 rounds.
Showing the 10 most recent of 135 filings.
See the complete cap table with every shareholder, founder tags, dilution across 28 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.